SE8304007D0 - Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling - Google Patents

Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling

Info

Publication number
SE8304007D0
SE8304007D0 SE8304007A SE8304007A SE8304007D0 SE 8304007 D0 SE8304007 D0 SE 8304007D0 SE 8304007 A SE8304007 A SE 8304007A SE 8304007 A SE8304007 A SE 8304007A SE 8304007 D0 SE8304007 D0 SE 8304007D0
Authority
SE
Sweden
Prior art keywords
sub
therapeutic
composition
therapeutic treatment
diagnostic use
Prior art date
Application number
SE8304007A
Other languages
English (en)
Swedish (sv)
Inventor
Karl-Anders Karlsson
Alf Lindberg
Original Assignee
Karlsson Karl Anders
Alf Lindberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karlsson Karl Anders, Alf Lindberg filed Critical Karlsson Karl Anders
Priority to SE8304007A priority Critical patent/SE8304007D0/xx
Publication of SE8304007D0 publication Critical patent/SE8304007D0/xx
Priority to AT84850212T priority patent/ATE96324T1/de
Priority to DE84850212T priority patent/DE3486236T2/de
Priority to EP84850212A priority patent/EP0132242B1/en
Priority to AU30528/84A priority patent/AU581851B2/en
Priority to FI842815A priority patent/FI842815A/fi
Priority to JP59144521A priority patent/JPS6064927A/ja
Priority to US06/630,576 priority patent/US4724205A/en
Priority to DK347784A priority patent/DK168272B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/24—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • G01N2333/25—Shigella (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/803—Physical recovery methods, e.g. chromatography, grinding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE8304007A 1983-07-15 1983-07-15 Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling SE8304007D0 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE8304007A SE8304007D0 (sv) 1983-07-15 1983-07-15 Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
AT84850212T ATE96324T1 (de) 1983-07-15 1984-07-04 Verbindung und zusammensetzung zur therapeutischen oder diagnostischen anwendung.
DE84850212T DE3486236T2 (de) 1983-07-15 1984-07-04 Verbindung und Zusammensetzung zur therapeutischen oder diagnostischen Anwendung.
EP84850212A EP0132242B1 (en) 1983-07-15 1984-07-04 A compound and a composition for therapeutic or diagnostic use
AU30528/84A AU581851B2 (en) 1983-07-15 1984-07-12 A compound and a composition for therapeutic or diagnostic use and a process for therapeutic treatment
FI842815A FI842815A (fi) 1983-07-15 1984-07-12 Foerening och komposition foer terapeutisk eller diagnostisk anvaendning och terapeutisk behandlingsmetod.
JP59144521A JPS6064927A (ja) 1983-07-15 1984-07-13 治療および診断用組成物
US06/630,576 US4724205A (en) 1983-07-15 1984-07-13 Diagnosis of Shigella dysenteriae
DK347784A DK168272B1 (da) 1983-07-15 1984-07-13 Præparat til terapeutisk og diagnostisk anvendelse samt fremgangsmåde til bestemmelse af tilstedeværelse af toxin fra Shigella Dysenteriae

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8304007A SE8304007D0 (sv) 1983-07-15 1983-07-15 Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling

Publications (1)

Publication Number Publication Date
SE8304007D0 true SE8304007D0 (sv) 1983-07-15

Family

ID=20351988

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8304007A SE8304007D0 (sv) 1983-07-15 1983-07-15 Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling

Country Status (9)

Country Link
US (1) US4724205A (xx)
EP (1) EP0132242B1 (xx)
JP (1) JPS6064927A (xx)
AT (1) ATE96324T1 (xx)
AU (1) AU581851B2 (xx)
DE (1) DE3486236T2 (xx)
DK (1) DK168272B1 (xx)
FI (1) FI842815A (xx)
SE (1) SE8304007D0 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561067B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
SE8304006D0 (sv) * 1983-07-15 1983-07-15 Karlsson Karl Anders Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
SE8406626D0 (sv) * 1984-12-27 1984-12-27 Bio Carb Ab Forening och komposition for terapeutisk eller diagnostisk anvendning jemte anvendning av sadan forening och komposition for terapeutisk behandling och isolering av shigatoxin
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
US5217715A (en) * 1988-08-01 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Carbohydrate receptor for bacteria and method for use thereof
DK455088D0 (da) * 1988-08-12 1988-08-12 Symbicom Ab Syntetiske receptoranaloger
SE9003222L (sv) * 1990-10-10 1992-04-11 Jens Sandros Preparat foer profylaktiskt,terapeutiskt och diagnostiskt bruk vid infektioner
US5310542A (en) * 1991-12-31 1994-05-10 Lever Brothers Company, Division Of Conopco, Inc. Oral hygiene compositions containing antiplaque agents
US5409902A (en) * 1991-12-31 1995-04-25 Lever Brothers Company Oral hygiene compositions containing glyceroglycolipids as antiplaque compounds
US6727061B2 (en) * 1997-02-20 2004-04-27 Cabtec, Inc. Methods for identifying species or Shigella and E. coli using operon sequence analysis
US5888750A (en) * 1997-05-30 1999-03-30 Synsorb Biotech, Inc. Method of recovering shiga-like toxins and vaccines comprising inactivated shiga-like toxin
US7135173B2 (en) * 2000-07-13 2006-11-14 Idaho Research Foundation, Inc. Antiviral activity of Shiga toxin
US6541013B1 (en) 2000-07-13 2003-04-01 Idaho Research Foundation, Inc. Methods and compositions for suppressing bovine leukemia virus with a Shiga toxin polypeptide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1188519A (en) * 1966-10-27 1970-04-15 Wellcome Found Method for the Purification of Lipopolysaccharides
US3891508A (en) * 1973-06-01 1975-06-24 Joseph M Merrick Method of rapid identification of gram-negative bacteria
SE8001748L (sv) * 1980-03-05 1981-09-06 Kaellenius Gunilla Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik
EP0058665B1 (en) * 1980-05-09 1986-02-26 LEFFLER, Hakon Carbohydrate derivatives for inhibiting bacterial adherence
EP0089940A1 (en) * 1982-03-23 1983-09-28 BioCarp AB Compositions for therapeutic or diagnostic use containing oligosaccharides
SE8304006D0 (sv) * 1983-07-15 1983-07-15 Karlsson Karl Anders Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling

Also Published As

Publication number Publication date
DE3486236D1 (de) 1993-12-02
FI842815A (fi) 1985-01-16
EP0132242B1 (en) 1993-10-27
AU581851B2 (en) 1989-03-09
DK347784D0 (da) 1984-07-13
EP0132242A2 (en) 1985-01-23
EP0132242A3 (en) 1989-02-08
ATE96324T1 (de) 1993-11-15
AU3052884A (en) 1985-01-17
US4724205A (en) 1988-02-09
DK168272B1 (da) 1994-03-07
DK347784A (da) 1985-01-16
JPS6064927A (ja) 1985-04-13
FI842815A0 (fi) 1984-07-12
DE3486236T2 (de) 1994-02-24

Similar Documents

Publication Publication Date Title
SE8304007D0 (sv) Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
FI864150A (fi) Kemiska foereningar.
GR3023938T3 (en) 3',5'-ditertbutyl-4'-hydroxyflavones, method for their preparation and pharmaceutical compositions with an antioxidant and antivasoconstricting activity
SE8304006D0 (sv) Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
ATE78845T1 (de) Pigmentzusammensetzung.
PH16317A (en) Piperidylidene derivatives,pharmaceutical composition containing same and method of use thereof
SE8100134L (sv) Terpenoider, forfaranden for framstellning av desamma och farmaceutiska kompositioner innehallande desamma
IT1090865B (it) Procedimento per l'eliminazione di residui radioattivi organici
NO834265L (no) Fremgangsmaate ved fremstilling av nye 6alfa-methylkortikoider
SE7910072L (sv) Pyrrolo- eller pyrido(2,1-c)(1,4)tiaziner eller -tiazepiner
AR240858A2 (es) Una composicion fungicida
IL65597A0 (en) Preparation of cholesterol derivatives
AU6826887A (en) 5-substituted octahydroindolizine analgesics compounds and 7-keto intermediates
ATE73136T1 (de) Verfahren zur herstellung von 6alpha, 9alphadifluor-11beta, 17alpha-dihydroxy-16alpha-methyl4-pregnen-3,20-dion und dessen derivate.
GB2087878B (en) Preparation of nocardicin by fermentation
SE7704830L (sv) Indazolderivat
GR74870B (xx)
GB2251613A (en) Substituted phenylsulphonyltriazinylurea and salts thereof and means for stimulating and suppressing plant growth based on them
ATE77744T1 (de) Verwendung von pyrrothinderivaten.
ES2051765T3 (es) 13 alfa-alquilgon-delta9(11)-en-5,10-epoxidos.
ES466775A1 (es) Procedimiento para la obtencion de un insecticida a base de un fosfuro hidrolizable finamente dividido.
KR840004431A (ko) 히단토인 치료제
FI824155A0 (fi) Foerfarande foer framstaellning av 3,7a-diazacyklohepta/j,k/fluoren
AU5977680A (en) Cyclophosphathiazene derivatives
GB2013653A (en) Cleavage of Ethereal Linkage